Childbirth Slows Progression of MS - Statement

September 29th, 2009 LONDON - In response to today's results from pharmaceutical firm Novartis on its oral multiple sclerosis (MS) therapy FTY-720 (fingolimod), the MS Society has released the following statement: MS Society Head of Research, Dr Lee Dunster, said: "The availability of oral therapies will herald a new dawn for people with MS and if trial results satisfy the regulator there could be a real alternative to inconvenient and unpleasant injections." Notes to Editors: Oral therapies in MS - There are currently two oral therapies in development for MS. - Fingolimod and cladribine (Merck Serono) both show similar reduction in relapse rates and disability progression.

August 31st, 2009 NATICK, Massachusetts and BARCELONA, Spain - - Results of Landmark Heart Failure Trial Published by New England Journal of Medicine and Presented at ESC Boston Scientific Corporation (NYSE: BSX) today announced final results from the landmark MADIT-CRT trial, which were published by the New England Journal of Medicine and presented during a Hot Line session at the annual European Society of Cardiology (ESC) Congress in Barcelona. Arthur Moss, M.D., Professor of Medicine at the University of Rochester Medical Center and Principal Investigator of the trial, presented the MADIT-CRT data.

July 19th, 2009 LONDON - - Most Women Admit to Letting Themselves go After Having Children and... - With Photo With so many celebrity mums losing their baby weight and looking glam within weeks of giving birth, there is more pressure than ever on the rest of us to look good after having kids.

June 15th, 2009 PARIS - Ronald D. Sugar, chairman and CEO of Northrop Grumman and Louis Gallois, CEO of EADS issued a joint statement today.

May 31st, 2009 ORLANDO, Florida - The time to progression of disease in patients with colorectal cancer liver metastases who have exhausted all chemotherapy options can be more than doubled through the use of radioactive resin microspheres, according to the results of a prospective randomized controlled trial presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).[1] The multicenter phase III study compared the use of 5-fluorouracil (5FU) alone to 5FU plus 90Y resin microspheres (SIR-Spheres; Sirtex Medical, Sydney) and was conducted by a collaboration of university hospitals in Belgium. "Patients with colorectal cancer liver metastases who are resistant or intolerant of chemotherapy should be considered for salvage therapy using 90Y resin microspheres combined with 5FU-based chemotherapy," said Dr Alain Hendlisz, Head of Digestive Oncology and Gastroenterology at Institut Jules Bordet Université Libre de Bruxelles, Brussels, Belgium, and principal investigator of the study.

May 25th, 2009 HALIFAX, Canada - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based , clinical stage company that develops DNA vaccines.

May 19th, 2009 AMSTERDAM - Internet Growth and Innovation Depends on Continued Availability of IP Addresses - Over 800 European Organisations Give Their Support to the "IPv6 Act Now" Statement to Urge Speedy and Efficient Adoption of IPv6 The RIPE NCC, the not-for-profit organisation that supports the infrastructure of the Internet, launches the IPv6 Act Now website today. With an Internet community position statement on IPv6 supported by over 800 organisations, the website explains the new Internet protocol in terms that everyone can understand.

May 5th, 2009 NEW YORK - Advanced Registration is Required Pershing Square Capital Management, L.P., announced today that it will host a Town Hall Meeting to provide all shareholders of Target Corporation (NYSE: TGT) and other interested parties the opportunity to meet each of its nominees for the Target Board of Directors. As seating is limited, in-person attendees must register in advance.

May 5th, 2009 LONDON - Micro Focus is set to attain a leading position in the Automated Software Quality market, with recommended offers to acquire both Borland Software Corporation and a division of Compuware. Stephen Kelly, Micro Focus Chief Exectuive, said the move was a "very logical progression" for the company and built on the products Micro Focus already offered in the testing space - a market valued at $2bn annually.

March 17th, 2009 LONDON - ATTN: Education, Careers & Politics Correspondents The UK's Apprenticeship renaissance could stall if careers information and guidance is not overhauled warns a major new report, Progression through Apprenticeships, published today. Leading educationalists, employers and apprentices gave evidence to the Skills Commission inquiry over a six-month period.

November 17th, 2009 TJX 3Q profit rises 32 pct as shoppers seek dealsNEW YORK — TJX Cos. Inc. says its fiscal third-quarter profit rose 32 percent as shoppers looked for bargains at the discount retailer's chains.

November 17th, 2009 Dubai Airshow: Boeing wins first orders for 737sDUBAI, United Arab Emirates — Boeing scored its first aircraft orders at the Dubai Airshow on Tuesday, getting requests for a total of 11 737-800 jetliners from two Algerian airlines. The Chicago-based plane maker had lagged behind European rival Airbus, which has announced deals every day since the show began Sunday.

November 22nd, 2009 Astronaut's baby daughter born as he circles EarthCAPE CANAVERAL, Fla. — Astronaut Randolph Bresnik jubilantly welcomed his new daughter into the world Sunday as he floated 220 miles above it.

November 23rd, 2009 Praxair to sell gases to Chinese solar cell makerSHANGHAI — Praxair Inc.'s Chinese unit has signed a multiyear agreement to sell gases that MAGI Solar Energy Technology Co. will use to make solar cells and modules, Praxair announced Monday.

November 17th, 2009 Mortgage delinquencies hit another record in 3QNEW YORK — The pace at which people fell behind on their mortgages slowed during the summer for the third consecutive quarter, but the overall delinquency rate hit another record, a new report shows. For the three months ended Sept.

November 17th, 2009 Boots & Coots files $250M shelf registrationHOUSTON — Boots & Coots Inc., an oil and gas exploration company, said Tuesday it has filed a universal shelf registration statement with the Securities and Exchange Commission to sell $250 million in securities but has no immediate plans to do so. Chief Financial Officer Cary Baetz said the statement will "help facilitate our future ability to raise capital to fund potential acquisitions, invest in other growth opportunities or repay debt." Boots & Coots is based in Houston.

November 19th, 2009 NEW DELHI - The right-wing Hindu group Bajrang Dal Thursday wrote letters to major trade associations and chambers of commerce in Delhi calling for a boycott of Chinese goods saying that China was using India as a "dumping market" for "cheap goods". Chinese goods are very inferior in quality standards and China is making India as a dumping market for its cheap goods.

November 17th, 2009 Va. inmate who killed 2 executed by electric chairJARRATT, Va. — A former Army counterintelligence worker was executed by electric chair Tuesday for killing a Virginia couple, becoming the first U.S.

November 23rd, 2009 NEW DELHI - International Finance Corp (IFC), a member of the World Bank group, will provide trade financing of $51 million to Kotak Mahindra Bank as part of its effort to help small and medium enterprises hit by the global meltdown. In a statement released Monday, IFC said the trade finance facility would provide Kotak Mahindra risk coverage.

November 21st, 2009 BANGALORE - Logistics firm DHL has signed a security partnership with Air India-Singapore Airport Terminal Services (SATS), the cargo terminal operator at the Bangalore international airport, to provide security to its freight customers, the company said Saturday. "The partnership aims to develop standard operating procedures to meet customers' security requirements for high-value and high-risk air cargo," DHL's freight forwarding division said in a statement here.